Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies

References

• HandAPolyuria and tuberculosisArch Pediatr189310673675
   Google Scholar
• RollinsBJGenomic alterations in Langerhans cell histiocytosisHematol Oncol Clin North Am201529583985126461146
   PubMed Web of Science ®Google Scholar
• KompDMHistorical perspectives of Langerhans cell histiocytosisHematol Oncol Clin North Am1987119213312151
   PubMedGoogle Scholar
• KompDMTherapeutic strategies for Langerhans cell histiocytosisJ Pediatr199111922742751861214
   PubMed Web of Science ®Google Scholar
• LadischSHistiocytosisWilloughbyMLSiegelSEButterworth’s International Medical Reviews: Pediatrics1London, UKButterworth Scientific198295109
   Google Scholar
• EgelerRMAnnelsNEHogendoornPCLangerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulationPediatr Blood Cancer200442540140315049009
   PubMed Web of Science ®Google Scholar
• FadeelBHenterJILangerhans-cell histiocytosis: neoplasia or unbridled inflammation?Trends Immunol2003248409410 author reply 410–41112909451
   PubMed Web of Science ®Google Scholar
• LichtensteinLHistiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entityAMA Arch Pathol19535618410213057466
   PubMedGoogle Scholar
• NezelofCBassetFRousseauMFHistiocytosis X histogenetic arguments for a Langerhans cell originBiomedicine19731853653714356601
   PubMedGoogle Scholar
• Histiocytosis syndromes in children. Writing Group of the Histiocyte SocietyLancet1987185262082092880029
   PubMed Web of Science ®Google Scholar
• FavaraBEFellerACPauliMContemporary classification of histiocytic disorders. The WHO Committee on histiocytic/reticulum cell proliferations. Reclassification Working Group of the Histiocyte SocietyMed Pediatr Oncol19972931571669212839
   PubMedGoogle Scholar
• ChuTJaffeRThe normal Langerhans cell and the LCH cellBr J Cancer Suppl199423S4S107521202
   PubMedGoogle Scholar
• CouryFAnnelsNRivollierALangerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusionNat Med2008141818718157139
   PubMed Web of Science ®Google Scholar
• IkawaYNishimuraRArakiRPathognomonic serum cytokine profiles identify life-threatening langerhans cell histiocytosisBr J Haematol Epub472016
   Web of Science ®Google Scholar
• KannourakisGAbbasAThe role of cytokines in the pathogenesis of Langerhans cell histiocytosisBr J Cancer Suppl199423S37S408075004
   PubMedGoogle Scholar
• EgelerRMFavaraBEvan MeursMLamanJDClaassenEDifferential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatmentBlood199994124195420110590064
   PubMed Web of Science ®Google Scholar
• RossoDAKarisJBraierJLHenterJIFadeelBElevated serum levels of the decoy receptor osteoprotegerin in children with langerhans cell histiocytosisPediatr Res200659228128616439593
   PubMed Web of Science ®Google Scholar
• RossoDARipoliMFRoyADiezRAZelazkoMEBraierJLSerum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosisJ Pediatr Hematol Oncol200325648048312794527
   PubMed Web of Science ®Google Scholar
• IshiiRMorimotoAIkushimaSHigh serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosisPediatr Blood Cancer200647219419916358318
   PubMed Web of Science ®Google Scholar
• WillmanCLBusqueLGriffithBBLangerhans’-cell histiocytosis (histiocytosis X) – a clonal proliferative diseaseN Engl J Med199433131541608008029
   PubMed Web of Science ®Google Scholar
• AricoMNicholsKWhitlockJAFamilial clustering of Langerhans cell histiocytosisBr J Haematol1999107488388810606898
   PubMed Web of Science ®Google Scholar
• SuricoGMuggeoPRigilloNGadnerHConcurrent Langerhans cell histiocytosis and myelodysplasia in childrenMed Pediatr Oncol200035442142511025473
   PubMedGoogle Scholar
• BettsDRLeibundgutKEFeldgesAPlussHJNiggliFKCytogenetic abnormalities in Langerhans cell histiocytosisBr J Cancer19987745525559484810
   PubMed Web of Science ®Google Scholar
• da CostaCEEgelerRMHoogeboomMDifferences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the diseaseJ Pathol2007212218819717447723
   PubMed Web of Science ®Google Scholar
• EgelerRMNegliaJPAricoMThe relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte SocietyHematol Oncol Clin North Am19981223693789561906
   PubMed Web of Science ®Google Scholar
• MagniMDi NicolaMCarlo-StellaCIdentical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursorLeuk Res200226121131113312443887
   PubMed Web of Science ®Google Scholar
• FeldmanALBertholdFArceciRJClonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosisLancet Oncol20056643543715925822
   PubMed Web of Science ®Google Scholar
• LamanJDLeenenPJAnnelsNEHogendoornPCEgelerRMLangerhans-cell histiocytosis “insight into DC biology”Trends Immunol200324419019612697451
   PubMed Web of Science ®Google Scholar
• HutterCKauerMSimonitsch-KluppINotch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cellsBlood2012120265199520823074278
   PubMed Web of Science ®Google Scholar
• WinterDRJungSAmitIMaking the case for chromatin profiling: a new tool to investigate the immune-regulatory landscapeNat Rev Immunol201515958559426272294
   PubMed Web of Science ®Google Scholar
• Badalian-VeryGVergilioJADegarBARecurrent BRAF mutations in Langerhans cell histiocytosisBlood2010116111919192320519626
   PubMed Web of Science ®Google Scholar
• BerresMLLimKPPetersTBRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsJ Exp Med2014211466968324638167
   PubMed Web of Science ®Google Scholar
• EmileJFAblaOFraitagSRevised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesBlood2016127222672268126966089
   PubMed Web of Science ®Google Scholar
• MinkovMMultisystem Langerhans cell histiocytosis in children: current treatment and future directionsPaediatr Drugs2011132758621351807
   PubMed Web of Science ®Google Scholar
• KompDMConcepts in staging and clinical studies for treatment of Langerhans’ cell histiocytosisSemin Oncol19911811823
   PubMed Web of Science ®Google Scholar
• LaheyEHistiocytosis X – an analysis of prognostic factorsJ Pediatr19758721841891151558
   PubMed Web of Science ®Google Scholar
• LaheyMEPrognostic factors in histiocytosis XAm J Pediatr Hematol Oncol19813157606972178
   PubMedGoogle Scholar
• MinkovMGroisNHeitgerAPotschgerUWestermeierTGadnerHResponse to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicatorMed Pediatr Oncol200239658158512376981
   PubMedGoogle Scholar
• DonadieuJPiguetCBernardFA new clinical score for disease activity in Langerhans cell histiocytosisPediatr Blood Cancer200443777077615390280
   PubMed Web of Science ®Google Scholar
• LavinPTOsbandMEEvaluating the role of therapy in histiocytosis-X. Clinical studies, staging, and scoringHematol Oncol Clin North Am19871135473499431
   PubMedGoogle Scholar
• TitgemeyerCGroisNMinkovMFlucher-WolframBGatterer-MenzIGadnerHPattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-studyMed Pediatr Oncol200137210811411496348
   PubMedGoogle Scholar
• BroadbentVGadnerHCurrent therapy for Langerhans cell histiocytosisHematol Oncol Clin North Am19981223273389561903
   PubMed Web of Science ®Google Scholar
• GadnerHGroisNAricoMA randomized trial of treatment for multisystem Langerhans’ cell histiocytosisJ Pediatr2001138572873411343051
   PubMed Web of Science ®Google Scholar
• AllenCELadischSMcClainKLHow I treat Langerhans cell histiocytosisBlood20151261263525827831
   PubMed Web of Science ®Google Scholar
• BroadbentVGadnerHKompDMLadischSHistiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte SocietyMed Pediatr Oncol19891764924952685528
   PubMedGoogle Scholar
• HauptRMinkovMAstigarragaILangerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 yearsPediatr Blood Cancer201360217518423109216
   PubMed Web of Science ®Google Scholar
• BerryDHGresikMMaybeeDMarcusRHistiocytosis X in bone onlyMed Pediatr Oncol19901842922942192248
   PubMedGoogle Scholar
• BolliniGJouveJLGentetJCJacquemierMBouyalaJMBone lesions in histiocytosis XJ Pediatr Orthop19911144694771860945
   PubMed Web of Science ®Google Scholar
• FiorilloASadileFDe ChiaraCBone lesions in Langerhans cell histiocytosisClin Pediatr (Phila)19933221181208432075
   PubMed Web of Science ®Google Scholar
• KilpatrickSEWengerDEGilchristGSShivesTCWollanPCUnniKKLangerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult casesCancer19957612247124848625073
   PubMed Web of Science ®Google Scholar
• LauLMStuurmanKWeitzmanSSkeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivorsPediatr Blood Cancer200850360761217973322
   PubMed Web of Science ®Google Scholar
• WomerRBRaneyRBJrD’AngioGJHealing rates of treated and untreated bone lesions in histiocytosis XPediatrics19857622862883875075
   PubMed Web of Science ®Google Scholar
• MorimotoAIshidaYSuzukiNNationwide survey of single-system single site Langerhans cell histiocytosis in JapanPediatr Blood Cancer20105419810219728332
   PubMed Web of Science ®Google Scholar
• CohenMZornozaJCangirAMurrayJAWallaceSDirect injection of methylprednisolone sodium succinate in the treatment of solitary eosinophilic granuloma of bone: a report of 9 casesRadiology198013622892937403498
   PubMed Web of Science ®Google Scholar
• EgelerRMThompsonRCJrVoutePANesbitMEJrIntralesional infiltration of corticosteroids in localized Langerhans’ cell histiocytosisJ Pediatr Orthop19921268118141452756
   PubMed Web of Science ®Google Scholar
• AblaOEgelerRMWeitzmanSLangerhans cell histiocytosis: current concepts and treatmentsCancer Treat Rev201036435435920188480
   PubMed Web of Science ®Google Scholar
• ArceciRJBrennerMKPritchardJControversies and new approaches to treatment of Langerhans cell histiocytosisHematol Oncol Clin North Am19981223393579561904
   PubMed Web of Science ®Google Scholar
• McClainKLDrug therapy for the treatment of Langerhans cell histiocytosisExpert Opin Pharmacother20056142435244116259575
   PubMed Web of Science ®Google Scholar
• MonsereenusornCRodriguez-GalindoCClinical characteristics and treatment of Langerhans Cell histiocytosisHematol Oncol Clin North Am201529585387326461147
   PubMed Web of Science ®Google Scholar
• DonadieuJBernardFvan NoeselMCladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 studyBlood2015126121415142326194764
   PubMed Web of Science ®Google Scholar
• GadnerHGroisNPotschgerUImproved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensificationBlood200811152556256218089850
   PubMed Web of Science ®Google Scholar
• GadnerHMinkovMGroisNTherapy prolongation improves outcome in multisystem Langerhans cell histiocytosisBlood2013121255006501423589673
   PubMed Web of Science ®Google Scholar
• MinkovMGroisNBroadbentVCeciAJakobsonALadischSCyclosporine A therapy for multisystem langerhans cell histiocytosisMed Pediatr Oncol199933548248510531573
   PubMedGoogle Scholar
• WeitzmanSBraierJDonadieuJ2′-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH): results of the LCH-S-98 protocol of the histiocyte societyPediatr Blood Cancer20095371271127619731321
   PubMed Web of Science ®Google Scholar
• MinkovMRodriguez-GalindoCTreatment of Langerhans cell histiocytosis: it is time to learn from the pastBr J Haematol2015171114814925816900
   PubMed Web of Science ®Google Scholar
• MinkovMSteinerMPotschgerUReactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registryJ Pediatr20081535700705705.e701e70218589441
   PubMed Web of Science ®Google Scholar
• MorimotoAKobayashiRMaedaMAsamiKBesshoFImashukuSImpact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patientsPediatr Blood Cancer2008504931932 author reply 93217729246
   PubMed Web of Science ®Google Scholar
• PollonoDReyGLatellaARossoDChantadaGBraierJReactivation and risk of sequelae in Langerhans cell histiocytosisPediatr Blood Cancer200748769669917252574
   PubMed Web of Science ®Google Scholar
• BernardFThomasCBertrandYMulti-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunctionEur J Cancer200541172682268916291085
   PubMed Web of Science ®Google Scholar
• SteinerMMatthes-MartinSAttarbaschiAImproved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioningBone Marrow Transplant200536321522515937510
   PubMed Web of Science ®Google Scholar
• AkkariVDonadieuJPiguetCHematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study GroupBone Marrow Transplant200331121097110312796789
   PubMed Web of Science ®Google Scholar
• AblaOWeitzmanSTreatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibitionHematol Am Soc Hematol Educ Program201520151565570
   Web of Science ®Google Scholar
• AllenCEParsonsDWBiological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disordersHematol Am Soc Hematol Educ Program20152015559564
   PubMed Web of Science ®Google Scholar
• BrownNAFurtadoLVBetzBLHigh prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosisBlood2014124101655165824982505
   PubMed Web of Science ®Google Scholar
• ChakrabortyRHamptonOAShenXMutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesisBlood2014124193007301525202140
   PubMed Web of Science ®Google Scholar
• DiamondELDurhamBHHarocheJDiverse and targetable kinase alterations drive histiocytic neoplasmsCancer Discov20166215416526566875
   PubMed Web of Science ®Google Scholar
• NelsonDSvan HalterenAQuispelWTMAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosisGenes Chromosomes Cancer201554636136825899310
   PubMed Web of Science ®Google Scholar
• HymanDMDiamondELVibatCRProspective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersCancer Discov201551647125324352
   PubMed Web of Science ®Google Scholar
• BubolzAMWeissingerSEStenzingerAPotential clinical implications of BRAF mutations in histiocytic proliferationsOncotarget20145124060407024938183
   PubMedGoogle Scholar
• CharlesJBeaniJCFiandrinoGBusserBMajor response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutationJ Am Acad Dermatol2014713e97e9925128147
   PubMed Web of Science ®Google Scholar
• HarocheJCohen-AubartFEmileJFDramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationBlood201312191495150023258922
   PubMed Web of Science ®Google Scholar
• HarocheJCohen-AubartFEmileJFReproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester diseaseJ Clin Oncol201533541141825422482
   PubMed Web of Science ®Google Scholar
• HeritierSJehanneMLevergerGVemurafenib use in an infant for high-risk Langerhans cell histiocytosisJAMA Oncol20151683683826180941
   PubMed Web of Science ®Google Scholar
• HymanDMPuzanovISubbiahVVemurafenib in multiple nonmelanoma cancers with BRAF V600 mutationsN Engl J Med2015373872673626287849
   PubMed Web of Science ®Google Scholar
• HarocheJCohen-AubartFEmileJFDonadieuJAmouraZVemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosisJ Am Acad Dermatol2015731e29e3026089069
   PubMed Web of Science ®Google Scholar
• BrownRECyclo-oxygenase-2 in the osteolytic lesions of Langerhans cell histiocytosisMed Pediatr Oncol200034431110742083
   PubMedGoogle Scholar
• BrownREBrief communication: morphoproteomic analysis of osteolytic Langerhans cell histiocytosis with therapeutic implicationsAnn Clin Lab Sci200535213113615943175
   PubMed Web of Science ®Google Scholar
• ArzooKSadeghiSPullarkatVPamidronate for bone pain from osteolytic lesions in Langerhans’-cell histiocytosisN Engl J Med2001345322511463032
   PubMed Web of Science ®Google Scholar
• BrownREMore on pamidronate in Langerhans’-cell histiocytosisN Engl J Med2001345201503
   Google Scholar
• ElomaaIBlomqvistCPorkkaLHolmstromTExperiences of clodronate treatment of multifocal eosinophilic granuloma of boneJ Intern Med1989225159612918272
   PubMed Web of Science ®Google Scholar
• KamizonoJOkadaYShirahataATanakaYBisphosphonate induces remission of refractory osteolysis in langerhans cell histiocytosisJ Bone Miner Res200217111926192812412797
   PubMed Web of Science ®Google Scholar
• MunnSEOlliverLBroadbentVPritchardJUse of indomethacin in Langerhans cell histiocytosisMed Pediatr Oncol199932424724910102016
   PubMedGoogle Scholar
• HenterJIKarlenJCalmingUBernstrandCAnderssonUFadeelBSuccessful treatment of Langerhans’-cell histiocytosis with etanerceptN Engl J Med20013452115771578
   PubMed Web of Science ®Google Scholar
• BrodowiczTHemetsbergerMWindhagerRDenosumab for the treatment of giant cell tumor of the boneFuture Oncol201511131881189426161925
   PubMed Web of Science ®Google Scholar
• DahiyaNKhadkaASharmaAKGuptaAKSinghNBrashierDBDenosumab: a bone antiresorptive drugMed J Armed Forces India2015711717525609868
   PubMedGoogle Scholar
• GoldenbergMMPharmaceutical approval updateP T201338844344524222975
   PubMedGoogle Scholar
• VaishyaRAgarwalAKVijayV“Salvage Treatment” of aggressive giant cell tumor of bones with denosumabCureus201577e29126251767
   PubMedGoogle Scholar
• HartCVogelhuberMWolffDAnakoinosis: communicative reprogramming of tumor systems – for rescuing from chemorefractory neoplasiaCancer Microenviron201582759226259724
   PubMedGoogle Scholar
• SenechalBElainGJeziorskiEExpansion of regulatory T cells in patients with Langerhans cell histiocytosisPLoS Med200748e25317696642
   PubMed Web of Science ®Google Scholar
• GatalicaZBilalovicNPalazzoJPDisseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1Oncotarget2015623198191982526110571
   PubMedGoogle Scholar